Not just research tools--proteasome inhibitors offer therapeutic promise (Q43943683)

28 November 2017

title

Not just research tools--proteasome inhibitors offer therapeutic promise (English)

1 reference

28 November 2017

Alfred L Goldberg

1

1 reference

28 November 2017

Kenneth Rock

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

8

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

338-340

1 reference

A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

The 26S proteasome: a molecular machine designed for controlled proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Proteasome inhibitors: from research tools to drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Proteasome inhibition in cancer: development of PS-341.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Degradation of cell proteins and the generation of MHC class I-presented peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

NF-kappaB signaling pathways in mammalian and insect innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Proteasome inhibition: A novel mechanism to combat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

inferred from DOI database lookup

7 January 2021

based on heuristic

Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-338

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0402-338

1 reference

28 November 2017

1 reference